Trials / Completed
CompletedNCT05316207
Tele-Nursing Follow-Up After Open Heart Surgery
Investigation of the Effect of Tele-Nursing on Anxiety And Complications in Patients With Open Heart Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Hasan Kalyoncu University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Introduction: Failure to follow-up patients by healthcare professionals after discharge may increase the development of anxiety and complications in patients. Aim: The aim of this study is to determine the effects of tele-nursing method to patients who have undergone Open Heart Surgery (OHS) after discharge on anxiety and some other complications. Material and Methods:This quasi-experimental randomized controlled study, which was conducted in a private hospital between November 2020 and April 2021, included 75 patients, 38 from the Intervention (IG) and 37 from the Control Group (KG). IG and CG patients were provided routine treatment and care. In addition to the IG, training and counselling were provided at least four times by phone calls between the first week after discharge and the end of the first month. Descriptive Form and State-Trait Anxiety Inventory (STAI-S and T) were administered to all patients before discharge, and STAI-S was administered at the end of the first month after discharge. Post-discharge complications were evaluated by medical doctor in both groups. These data, number of hospitalization and readmission rates were obtained from hospital records.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Telenursing | From the end of the first week after discharge to the end of the first month, patients were counseled over the phone during the home process. Complications were followed up. |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-04-21
- Completion
- 2021-04-21
- First posted
- 2022-04-07
- Last updated
- 2022-04-07
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05316207. Inclusion in this directory is not an endorsement.